A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071092
- By:
- Publication type:
- Article
Works by Wuyi Zeng
Results: 3
1
2
Capitalization Accounting of Data Factor: Theoretical Mechanism, Methodological Path, and Statistical Measurement.
- Published in:
- Journal of Official Statistics (JOS), 2024, v. 40, n. 3, p. 425, doi. 10.1177/0282423X241249116
- By:
- Publication type:
- Article
3
A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.925217
- By:
- Publication type:
- Article